Home › Funds › DJE Kapital AG › JNJ

DJE Kapital AG position in JNJ

JOHNSON & JOHNSON · Health Care

DJE Kapital AG reported holding 767,300 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$203.6M, representing 3.88% of its reported portfolio and ranking #9 among its reported holdings. DJE Kapital AG has disclosed JNJ holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)767.30K sh
Reported value held$203.57M
Portfolio Weight3.88%
First reportedQ4 2024
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How DJE Kapital AG's JNJ position evolved

DJE Kapital AG first disclosed a stake in JNJ in Q4 2024 at 19,364 shares (US$2.8M). The position peaked in Q3 2026 at 767,300 shares, worth US$203.6M. Across 8 filings, DJE Kapital AG increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 767,300 shares valued at US$203.6M — an increase of 256,618 shares quarter over quarter.. Notable position changes include a 3634% increase in Q4 2025 (shares rose 18% over the following quarter), a 32% trim in Q2 2026 (shares rose 4% over the following quarter), a 50% increase in Q3 2026 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 19.36K $2.79M New
Q1 2025 19.36K $3.22M Hold
Q2 2025 22.13K $3.37M Add
Q3 2025 22.13K $3.37M Hold
Q4 2025 826.38K $171.15M Add
Q1 2026 751.44K $182.70M Reduce
Q2 2026 510.68K $133.99M Reduce
Q3 2026 767.30K $203.57M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has DJE Kapital AG held JNJ?

DJE Kapital AG has disclosed JNJ holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is DJE Kapital AG's current position in JNJ?

As of Q3 2026, DJE Kapital AG holds 767.30K shares of JNJ (JOHNSON & JOHNSON), valued at $203.57M, representing 3.88% of its reported portfolio and ranking #9.

Has DJE Kapital AG been buying or selling JNJ?

In the latest 13F filing (Q3 2026), DJE Kapital AG increased its position in JNJ. The position peaked in Q3 2026 at 767.30K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.